Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract

doi:10.4239/wjd.v14.i7.1077

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4417)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

2780

Figures (1-7)

317

Tables (1-2)

308

Sum=3508

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

169

Download

566

Sum=735

Jul 15, 2023 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Jul 15, 2023; 14(7): 1077-1090
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1077

Full Size Figure Download Figure

Figure 1 Workflow of the experimental design. m6A: N6-methyladenosine; QC: Quality control; IP: Immunoprecipitation.

Citation: Cai L, Han XY, Li D, Ma DM, Shi YM, Lu Y, Yang J. Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract. World J Diabetes 2023; 14(7): 1077-1090
URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1077.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i7.1077